altRx
Metabolic-Fit 56/100 · Grade C
One of the lowest listed prices for compounded GLP-1s — $89 a month for semaglutide and $149 for tirzepatide, the same at every dose, with the visit, supplies and shipping included — from a company that received an FDA warning letter in June 2026 and treats every payment as final. Cancellation needs 72 hours' notice, and a documented trinitymeds trademark connection deserves attention.
- $10 less per month on average than SnagRx
- serves all 50 states, where SnagRx lists Not published
- offers FDA-approved brand pens, not just compounded
ShedRx
Metabolic-Fit 76/100 · Grade C
The widest menu on our list — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, prices published for every plan length, and cancellation terms among the most restrictive we have read.
- serves all 50 states, where SnagRx lists Not published
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
LumiMeds
Metabolic-Fit 49/100 · Grade C
LumiMeds carries a 2025 FDA warning letter over how it described its compounded medication. Semaglutide: $89/mo advertised flat rate; tirzepatide: $125/mo advertised flat rate. The promotion promises a price lock, but terms reserve price changes, restrict mid-term cancellation and apply a $100 deduction to applicable refunds.
- $10 less per month on average than SnagRx
- serves all 50 states, where SnagRx lists Not published
Midi Health
Metabolic-Fit 72/100 · Grade C
A menopause-focused program that bills insurance for eligible visits. The visit is covered in network or $250 self-pay, and the medication is billed separately from $164 per four-week supply — both figures published. It's built for perimenopause, not the postpartum year.
- serves all 50 states, where SnagRx lists Not published
- offers FDA-approved brand pens, not just compounded
- scores 72/100 against SnagRx's 56
Mondae
Metabolic-Fit 46/100 · Grade C
Mondae lists semaglutide at $87 a month and tirzepatide at $126 with a one-month plan. Its lower $69 and $114 averages require six-month prepayments of $414 and $684.
- $12 less per month on average than SnagRx
- serves all 50 states, where SnagRx lists Not published
Breeze Meds
Metabolic-Fit 78/100 · Grade C
Semaglutide: $199/mo; tirzepatide: Starting at $399/mo. Oral semaglutide starts at $299 and oral tirzepatide at $399; confirm your dose, plan length and cancellation terms.
- serves all 50 states, where SnagRx lists Not published
- has an oral option if you would rather not inject
- scores 78/100 against SnagRx's 56
Trimi Health
Metabolic-Fit 80/100 · Grade B−
Price-first and nationwide: flat, all-inclusive compounded pricing at $175 and $235 month to month, down to $99 and $125 on a 12-month plan — strong if you read the prepay fine print.
- serves all 50 states, where SnagRx lists Not published
- scores 80/100 against SnagRx's 56
yourEra
Metabolic-Fit 76/100 · Grade C
A low-entry, all-in compounded program with both molecules, one price at every dose and a clean cancel-anytime policy — appealing, though the 'from' price isn't explained and the outcome claims are unverified marketing.
- $20 less per month on average than SnagRx
- scores 76/100 against SnagRx's 56
NextMeds
Metabolic-Fit 39/100 · Grade C
Its recorded operator, Trinity HealthCare Supply LLC dba altRx, received FDA warning letter 728236 concerning another website. NextMeds’ current catalog lists semaglutide at $79 a month and tirzepatide at $129, with the same renewal prices. Its $49 headline requires the $588 annual semaglutide plan.
- $20 less per month on average than SnagRx
- serves all 50 states, where SnagRx lists Not published